Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs for the Treatment of COVID-19
NCT04444271Phase 2Unknown
- Start
- May 2020
- Primary completion
- Aug 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04444271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04444271.